azoxymethane has been researched along with acrolein in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, T; Long, M; Park, SL; Rojo de la Vega, M; Tao, S; Wen, Q; Wondrak, GT; Zhang, DD | 1 |
| Epifano, F; Fiorito, S; Genovese, S; Ibuka, T; Ideta, T; Kubota, M; Maruta, A; Miyazaki, T; Mizutani, T; Sakai, H; Shimizu, M; Shirakami, Y; Taddeo, VA; Tanaka, T | 1 |
2 other study(ies) available for azoxymethane and acrolein
| Article | Year |
|---|---|
Nrf2-dependent suppression of azoxymethane/dextran sulfate sodium-induced colon carcinogenesis by the cinnamon-derived dietary factor cinnamaldehyde.
Topics: Acrolein; Animals; Anticarcinogenic Agents; Azoxymethane; Carcinogenesis; Chemoprevention; Cinnamomum zeylanicum; Colonic Neoplasms; Cytoprotection; Dextran Sulfate; Diet; HCT116 Cells; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-E2-Related Factor 2 | 2015 |
Novel FXR agonist nelumal A suppresses colitis and inflammation-related colorectal carcinogenesis.
Topics: Acrolein; Animals; Azoxymethane; Carcinogenesis; Carcinogens; Colitis; Colorectal Neoplasms; Dextran Sulfate; Disease Models, Animal; Inflammation; Male; Mice; Mice, Inbred A; RNA-Binding Proteins | 2021 |